...Santiago Richter; Israel Nissenkorn; Mordechai Rotbard; David Slutzker A new technique is described for the treatment of benign prostatic hyperplasia with local hyperthermia applied transurethrally by an electromagnetic wave generator. A series of 72 treatment sessions given to 16 patients...

...Manabu Ishigooka; Shinsuke Hayami; Yasuhiro Suzuki; Tohru Hashimoto; Isoji Sasagawa; Teruhiro Nakada To clarify the effect of aging on the histological composition of established benign prostatic hyperplasia (BPH), quantitative morphometric analyses were performed. Specimens were obtained from 23...

...Kjell J. Tveter; Lars M. Eri Casodex, a new nonsteroidal antiandrogen, was investigated in this doubleblind,randomized, placebo-controlled study comprising 28 evaluable patients with benign prostatic hyperplasia, who received Casodex at a dosage of 50 mg daily or a placebo for 24 weeks. The good...

...Gianfranco Savoca; Stefano de Stefani; Ignazio Gattuccio; Daniele Paolinelli; Fulvio Stacul; Emanuele Belgrano Objective: To evaluate the feasibility, safety and efficacy of a minimally invasive treatment for benign prostatic hyperplasia (BPH) consisting of percutaneous ethanol injection inside...

... scores and quality of life score. Methods: Males with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH), were consecutively included in the study if they met the criteria of the International Consensus Committee on BPH, they voided >150 ml during uroflowmetry, residual volume...

... words including prostatic hyperplasia, treatment, surgery, thermal treatments, thermotherapy, laser, TUNA and vaportrode. Data from both randomised and non-randomised controlled trials were considered. Results: All invasive treatments produce significant changes of all subjective and objective outcome...

...Karel W.H. Gisolf; Ger E.P.M. van Venrooij; Mardy D. Eckhardt; Tom A. Boon Objectives: The aims of this study were to analyse the data from frequency–volume charts and to study the reliability of these charts in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH...

...J. Teun Bousema; Marion J.G. Bussemakers; Kjeld P. van Houwelingen; Frans M.J. Debruyne; André L.M. Verbeek; Jean J.M.C.H. de la Rosette; Lambertus A. Kiemeney Objective: Little is known about risk factors for the development of benign prostatic hyperplasia (BPH). Recently, associations were...

...Andrea Tubaro; Emanuele Montanari Objective: To investigate the management of symptomatic benign prostatic hyperplasia (BPH) in Italy. Methods: Information on diagnosis, medical and surgical treatment was obtained from two different questionnaires independently mailed to urological centers in Italy...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic hyperplasia Therapeutic modalities Treatment selection...

...Sadettin Küpeli; Sümer Baltacι; Tarkan Soygür; Suat Aytaç; Erdal Yilmaz; Mehmet Budak Objective: The common goals of new surgical treatment for benign prostatic hyperplasia (BPH) are to improve subjective and objective symptoms, to decrease the risk of postoperative complications and short...